STOCK CAPITAL (Tables)
9 Months Ended
Sep. 30, 2019
STOCK CAPITAL  
Schedule of share-based compensation expense for restricted stock

 

 

 

 

 

 

 

 

    

 

    

 

    

Weighted Average

 

 

 

 

 

 

Remaining

 

 

Number of Shares

 

Weighted Average

 

Contractual

 

 

of Restricted

 

Grant Date Fair

 

Term

 

 

Stock

 

Value

 

(Years)

Nonvested as of December 31, 2018

 

152,908

 

3.96

 

1.56

Granted

 

88,012

 

3.96

 

  

Vested

 

60,979

 

3.32

 

  

Forfeitures

 

 —

 

 —

 

  

Nonvested as of September 30, 2019

 

179,941

 

3.98

 

1.99

 

Summary of the Company's option activity

A summary of the Company’s option activity related to options to employees and directors, and related information is as follows:

 

 

 

 

 

 

 

 

 

For the Nine months ended

 

 

September 30, 2019

 

    

 

    

Weighted

    

 

 

 

 

 

average

 

Aggregate

 

 

Amount of

 

exercise

 

intrinsic

 

 

options *

 

price

 

value

 

 

 

 

$

 

$

Outstanding at beginning of period

 

1,496,287

 

3.0581

 

  

Granted

 

204,167

 

4.8937

 

  

Exercised

 

(18,665)

 

1.8943

 

  

Cancelled

 

(253,514)

 

4.0996

 

  

Outstanding at end of period

 

1,428,275

 

3.1509

 

1,069,975

Vested and expected-to-vest at end of period

 

881,564

 

2.0076

 

1,668,280


*    Represents Employee Stock Options only (not including RSUs).

Schedule of total stock-based compensation expense

The total stock-based compensation expense, related to shares, options and warrants granted to employees, directors and service providers was comprised, at each period, as follows:

 

 

 

 

 

 

 

Nine months ended

 

 

September 30, 

 

    

2019

    

2018

 

 

 

 

 

Research and development

 

91

 

73

General and administrative

 

516

 

525

Total stock-based compensation expense

 

607

 

598